Succinylacetone

ChemistryAlso known as: SAAlso known as: 4-oxo-5-ureidovaleric acidumol/L

Measures succinylacetone in blood to screen for tyrosinemia type 1.

Normal Range
0.3 umol/L
umol/L
Abnormal Levels
Consult your provider
Specimen Type
Blood

Why This Biomarker Matters

Elevated succinylacetone indicates tyrosinemia type 1, a serious genetic disorder. Newborn detection enables early dietary and medical treatment preventing liver failure and kidney disease.

Understanding Your Results

Normal Range

0.3 umol/L

Overview

Succinylacetone is a toxic compound produced in tyrosinemia type 1, a rare genetic metabolic disorder affecting amino acid processing. This newborn screening test uses bloodspot analysis to measure succinylacetone levels, as elevated levels indicate impaired liver enzyme function. Tyrosinemia type 1 causes progressive liver disease, kidney dysfunction, neurological problems, and increased cancer risk without treatment. Early detection through newborn screening allows prompt initiation of dietary restriction and medications to prevent liver failure, kidney damage, and other serious complications.

Technical Information (LOINC Codes)

Standardized laboratory codes for this biomarker

75079-4Primary
Succinylacetone [Moles/volume] in Serum or Plasma
umol/L
53231-7
Succinylacetone [Moles/volume] in DBS
umol/L
30483-2
Succinylacetone [Presence] in Urine
38912-2
Succinylacetone [Moles/volume] in Amniotic fluid
mmol/L
42677-5
Succinylacetone [Molar amount] in DBS
um
74957-2
Succinylacetone [Moles/volume] in Plasma
nmol/L

Available Lab Tests

Order tests that measure this biomarker

Succinylacetone: Normal Range, Testing & Clinical Significance | Healos | Healos